Glaucoma News

The implantation of a single trabecular microbypass stent provided stable, long-term IOP and medication reduction in a real-life cohort of eyes with a variety of glaucoma types and severity.

Nocturnal IOP-related fluctuations are significantly more pronounced in medically treated than in surgically treated glaucoma, according to a study.

Cataract surgery helps lower IOP in patients with glaucoma but does not slow or prevent progressive visual field loss, according to a study.

The telemedicine glaucoma detection process has shown potential in being used both nationally and internationally.

Aerie Pharmaceuticals has initiated dosing in a phase 2 clinical trial of netarsudil ophthalmic solution in Japan, according to a press release.

Novartis announced that its spinoff of Alcon is expected to be completed April 9.

NEW YORK – Justin Schweitzer, OD, discussed the importance of collaborative care in glaucoma here at Vision Expo East.

NEW YORK – OCT angiography provides clinical information that was not previously accessible, Julie Rodman, OD, FAAO, said here at Vision Expo East.

SAN FRANCISCO — A machine-to-machine method of deep learning may lead to a more accurate way to estimate the presence of glaucoma from photographs, according to a speaker.

NEW YORK – The new 24-2C visual field protocol, now available on the Humphrey Field Analyzer 3 (Carl Zeiss Meditec), allows clinicians to “look at the classic 24-2 pattern, but also at macular points,” Daniel Epshtein, OD, said here at Vision Expo East.